Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Why we will never work with the tobacco industry.

Hays JT, Hurt RD.

Addiction. 2019 Feb 11. doi: 10.1111/add.14582. [Epub ahead of print] No abstract available.

PMID:
30746811
2.

Tobacco Dependence Treatment Grants: A Collaborative Approach to the Implementation of WHO Tobacco Control Initiatives.

Nolan MB, Kemper KE, Glynn TJ, Hurt RD, Hays JT.

J Environ Public Health. 2018 Mar 22;2018:8429738. doi: 10.1155/2018/8429738. eCollection 2018.

3.

Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.

Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM.

JAMA Intern Med. 2018 May 1;178(5):622-631. doi: 10.1001/jamainternmed.2018.0397.

4.

Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.

Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT.

Drug Alcohol Depend. 2018 Mar 1;184:12-17. doi: 10.1016/j.drugalcdep.2017.11.017. Epub 2018 Jan 2.

5.

An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.

Graham AL, Burke MV, Jacobs MA, Cha S, Croghan IT, Schroeder DR, Moriarty JP, Borah BJ, Rasmussen DF, Brookover MJ, Suesse DB, Midthun DE, Hays JT.

Trials. 2017 Nov 28;18(1):568. doi: 10.1186/s13063-017-2312-x.

6.

Implementing evidence-based smoking cessation treatment in psychosocial care units (CAPS) in Brazil.

Castaldelli-Maia JM, da Silva NR, Campos MR, Moura HF, Zabert G, Champagne BM, Kemper KE, Hays JT.

Int J Soc Psychiatry. 2017 Dec;63(8):669-673. doi: 10.1177/0020764017731462. Epub 2017 Sep 18.

PMID:
28920521
7.

Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

Hurt RT, Croghan IT, Schroeder DR, Hays JT, Choi DS, Ebbert JO.

Nicotine Tob Res. 2017 Aug 1;19(8):994-998. doi: 10.1093/ntr/ntw304.

8.

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.

Burke MV, Hays JT, Ebbert JO.

Patient Prefer Adherence. 2016 Apr 1;10:435-41. doi: 10.2147/PPA.S83469. eCollection 2016. Review.

9.

Treatment Outcomes From a Specialist Model for Treating Tobacco Use Disorder in a Medical Center.

Burke MV, Ebbert JO, Schroeder DR, McFadden DD, Hays JT.

Medicine (Baltimore). 2015 Nov;94(44):e1903. doi: 10.1097/MD.0000000000001903.

10.

Review and evaluation of online tobacco dependence treatment training programs for health care practitioners.

Selby P, Goncharenko K, Barker M, Fahim M, Timothy V, Dragonetti R, Kemper K, Herie M, Hays JT.

J Med Internet Res. 2015 Apr 17;17(4):e97. doi: 10.2196/jmir.3284.

11.

Impact of a countywide smoke-free workplace law on emergency department visits for respiratory diseases: a retrospective cohort study.

Croghan IT, Ebbert JO, Hays JT, Schroeder DR, Chamberlain AM, Roger VL, Hurt RD.

BMC Pulm Med. 2015 Jan 22;15:6. doi: 10.1186/1471-2466-15-6.

12.

Helping smokers quit in the "real world".

Hays JT.

Mayo Clin Proc. 2014 Oct;89(10):1328-30. doi: 10.1016/j.mayocp.2014.08.009. No abstract available.

PMID:
25282428
13.

Self-report of tobacco use status: comparison of paper-based questionnaire, online questionnaire, and direct face-to-face interview--implications for meaningful use.

Steffen MW, Murad MH, Hays JT, Newcomb RD, Molella RG, Cha SS, Hagen PT.

Popul Health Manag. 2014 Jun;17(3):185-9. doi: 10.1089/pop.2013.0051. Epub 2014 Jan 29.

14.

Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.

Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD.

JAMA. 2014 Jan 8;311(2):155-63. doi: 10.1001/jama.2013.283185.

15.

Cigarette smoking in methadone maintained patients: an up-to-date review.

Zirakzadeh A, Shuman C, Stauter E, Hays JT, Ebbert JO.

Curr Drug Abuse Rev. 2013 Mar;6(1):77-84. Review.

PMID:
23506370
16.

Preventing lung cancer by treating tobacco dependence.

Hurt RD, Ebbert JO, Hays JT, McFadden DD.

Clin Chest Med. 2011 Dec;32(4):645-57. doi: 10.1016/j.ccm.2011.08.004. Review.

PMID:
22054877
17.

Pharmacologic agents for tobacco dependence treatment: 2011 update.

Hays JT, McFadden DD, Ebbert JO.

Curr Atheroscler Rep. 2012 Feb;14(1):85-92. doi: 10.1007/s11883-011-0211-2. Review.

PMID:
22002681
18.

Spirituality in tobacco dependence: a Mayo Clinic survey.

McFadden D, Croghan IT, Piderman KM, Lundstrom C, Schroeder DR, Hays JT.

Explore (NY). 2011 May-Jun;7(3):162-7. doi: 10.1016/j.explore.2011.02.003.

PMID:
21571235
19.

A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.

Ebbert JO, Croghan IT, Severson HH, Schroeder DR, Hays JT.

Nicotine Tob Res. 2011 Sep;13(9):820-6. doi: 10.1093/ntr/ntr078. Epub 2011 Apr 18.

20.

Residential treatment compared with outpatient treatment for tobacco use and dependence.

Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, Hurt RD.

Mayo Clin Proc. 2011 Mar;86(3):203-9. doi: 10.4065/mcp.2010.0703. Epub 2011 Feb 9.

Supplemental Content

Loading ...
Support Center